Dr. Marta Catalfamo, Dr. Marc Siegel and Dr. Nina Yamanis named DC CFAR Core Co-Directors | |
|
The DC CFAR developed an Associate Core Director pathway program to help prepare the next generation of HIV investigators for CFAR leadership as Core Directors and Co-Directors. This program has been highly successful with multiple members of the current DC CFAR Executive Committee having served previously as Associate Core Directors including Dr. Seble Kassaye (Director, CPS Core), Dr. Alberto Bosque (Co-Director, Basic Science Core), Dr. Mark Burke (Co-Director, Developmental Core) and Dr. David Huebner (Co-Director, SBS Core).
Today the DC CFAR is proud to announce that three additional Associate Core Directors will be transitioning to Core Co-Director positions and joining the DC CFAR Executive Committee this fall:
| |
|
Dr. Marta Catalfamo will serve as a Co-Director of the DC CFAR Basic Science Core.
Dr. Catalfamo is an Associate Professor in the Department of Microbiology and Immunology, School of Medicine, at Georgetown University. Dr. Catalfamo is an R01-funded HIV laboratory investigator who also co-leads the DC CFAR Aging and Comorbidities Scientific Interest Group.
| |
|
Dr. Marc Siegel will serve as a Co-Director of the Clinical and Population Sciences Core.
Dr. Siegel is a Professor in the Department of Medicine, School of Medicine and Health Services at George Washington University. He is also Director of the Division of Infectious Diseases at the GW Medical Faculty Associates, MPI of the DC CTU, and the CRS Leader of the GW HPTN Clinical Research Site.
| |
|
Dr. Nina Yamanis will serve as a Co-Director of the Social and Behavioral Sciences Core.
Dr. Yamanis is an Associate Professor in the School of International Service and Assistant Dean for Faculty Affairs in the School of International Service at American University. Dr. Yamanis also leads both the DC CFAR Latina/o/x Scientific Interest Group and the MACC Latinx Scientific Working Group.
| |
|
Please join us in congratulating Drs. Catalfamo, Siegel and Yamanis on their new Core Co-Director roles in the DC CFAR!
| |
Mid-Atlantic CFAR Consortium (MACC) Scholars Program Cohort 3 (2024 – 2025) RFA Now Available! Applications due by December 15, 2023 |  | |
The Mid-Atlantic Centers for AIDS Research Consortium (MACC) Scholars Program is excited to announce this invitation to apply to be a MACC Scholar in the third cohort of early stage career investigators. The MACC Scholars Program is a collaboration between the District of Columbia (DC) CFAR, the Johns Hopkins University (JHU) CFAR, and the University of Pennsylvania (UPenn) CFAR.
The goal of the MACC Scholars Program is to support the development of new investigators with an interest in HIV among diverse populations in the Mid-Atlantic region, and to encourage their development as independent HIV investigators.
Up to $20,000 total costs can be used to implement a new pilot research project of which up to $5,000 can be used to enhance professional opportunities. This can include up to 10% faculty time if coverage is required to conduct the pilot, funds to conduct the study, attend conferences, receive leadership or scientific training, travel to other CFARs, or other costs as justified by the applicant. All Scholars will receive professional mentorship from MACC Scholar faculty at each of the collaborating CFARs and the opportunity to network with CFAR membership as they build their careers.
Please view the full RFA linked here.
Please address questions to Dr. Manya Magnus, at manyadm@gwu.edu
| |
New Publication on Syphilis Treatment Disparities in Washington, DC by Georgetown and DC Health Researchers | |
A new publication entitled "The Tenacious Treponema: A Retrospective Examination of Syphilis Treatment Disparities in Washington, DC" by Liroff, Kaitlin; Kassaye, Seble; Spence, Amanda B; Kumar, Princy; Natarajan, Madhuri; Harold, Rachel; Dorsey, Kerri; Doshi, Rupali K; Visconti, Adam J.2 , was recently published in the Journal of Sexually Transmitted Diseases. (Bold denotes CFAR affiliation). The publication includes DC CFAR researchers from Georgetown University and the DC Department of Health. Kerri Dorsi and Rupali Doshi hold secondary appointments/affiliations with the Milken School of Public Health at GWU.
Read the full publication available here
| | |
CFAR AFRICURE RFA Released: Call for Applicants by November 10th, 2023 |  | |
Through the CFAR Africure Program, the NIH-funded Centers for AIDS Research (CFARs) are working to advance HIV Cure research in Africa by providing mentored development to early- and mid-career investigators whose research focuses on HIV Cure strategies.
The AFRICURE program will award five grants of $150,000 for one year, plus applicable indirect costs. Recipients of the awards will be
mentored by and collaborate with established HIV investigators across CFARs and affiliated institutions in Africa, with the goal of having a transformational impact on the careers of African investigators, their institutions, and the entire HIV cure enterprise. Africure projects are single Principal Investigator (PI) awards. CFAR Africure awards are funded for a one-year period.
CFAR Africure projects are selected through a two-stage process:
- Submitted concept proposals are competitively reviewed
- Concept Proposal due: November 10, 2023
- Notification of Outcome: November 27, 2023
- A subset of reviewed concept proposals is invited to submit full applications
For more information on how to apply, and eligibility criteria, click here.
| |
New Publications by Dr. Rachel Scott regarding PrEP usage in Women and Pregnant People | |
Dr. Rachel Scott, Attending Physician of Obstetrics and Gynecology, and Associate Professor, Georgetown University, has published multiple articles this past year in the Journal of AIDS Patient Care, Women's Health Issues, and Frontiers in Reproductive Health all relating to PrEP. Please see the articles linked below:
Implementation of an Educational Intervention to Improve HIV Pre-Exposure Prophylaxis Services for Women in an Urban Sexual Health Clinic. Scott, R. K., Deyarmond, M., Marwitz, S., Huang, J. C., Moriarty, P., Visconti, A. J., Beverley, J., Elion, R., Coleman, M., & Hull, S. J. (2023).
Intention to Initiate HIV Pre-exposure Prophylaxis Among Cisgender Women in a High HIV Prevalence U.S. City Scott, R. K., Hull, S. J., Huang, J. C., Ye, P. P., Lotke, P., Beverley, J., Moriarty, P., Balaji, D., Ward, A., Holiday, J., Brant, A. R., Elion, R., Visconti, A. J., & Coleman, M. (2023).
Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy. Scott, R. K., Yu, Y., Marzinke, M. A., Coleman, J. S., Hendrix, C. W., & Bies, R. (2023).
Understanding Retention in the HIV Pre-Exposure Prophylaxis Cascade Among Cisgender Women
Burns, J. A., Hull, S. J., Inuwa, A., Moriarty, P., & Scott, R. K. (2023).
| | |
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. | |
FUNDING, TRAINING, & MENTORING OPPORTUNITIES/SEMINARS | |
|
UCSF-Bay Area CFAR Monthly Seminar: Elvin Geng w/ESI Speaker, Hannah Leslie (Hybrid)
"The monthly CFAR Seminar Series brings together the UCSF CFAR community to hear important updates in HIV science from world-class HIV researchers and local early-stage investigators."
Register for the hybrid event on November 1st, 12:30PM EST via Zoom, here.
NIDA Diversity Scholars Network Program Pre-Application Webinar
Are you an early-career investigator planning to submit a grant to NIH? Interested in collaborating and networking with other researchers? Looking to enhance your grant-writing capabilities and participate in a mock review meeting? Join the NIDA, Office of Diversity and Health Disparities on Wednesday, November 8, 2023, from 1:30-2:30 PM ET, and learn about the NIDA Diversity Scholars Network Program!
HIV Prevention Research Seminar with Drs. Maria Pyra and Jade Pagkas-Bather
On November 13th, at 12pm EST, "[at] this Third Coast CFAR seminar, Maria Pyra, PhD, MPH, of Northwestern University, and Jade Pagkas-Bather, MD, of University of Chicago, will present findings from their CFAR pilot awards. Pyra will present "Persistence, Risk, and Decision-Making Among a PrEP Using Cohort: A Mixed-Methods Study” and Pagkas-Bather will present "Examining Preferred ARV Implementation Strategies Among Young Black MSM: A Multilevel Approach." Zoom registration here.
AVAC: HPTN 096: Building Equity Through Advocacy – An Integrated, Status-Neutral Approach for Ending the Epidemic Among Black Gay Men in the South
"Please join The Choice Agenda and partners on November 15 for a fascinating discussion about a novel, much-needed HIV prevention research study – HPTN 096. Currently in the field, the study addresses social, structural, institutional, and behavioral barriers to HIV prevention and care."
Register here.
ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed)
The National Institutes of Health (NIH) Office of Disease Prevention (ODP) and participating Institutes, Centers, and Offices are inviting applications to develop T32 programs to train predoctoral scholars from diverse backgrounds in all three of the following areas: Health disparities/health equity research, Development and implementation of multi-level preventive interventions, and Methods for the design and analysis of studies to evaluate multi-level preventive interventions. See full announcement here.
Post-Doctoral (T32) Training Program in Ending the HIV Epidemic – Application Open at Emory University
Emory Training Program in Translational Research to End the HIV Epidemic is now accepting applications to fill postdoctoral slots for January and July 2024. The program will offer a continuous rolling application and deadlines will vary depending on the intended start date. More information here.
| |
OTHER OPPORTUNITIES, NEWS, AND RESOURCES
| |
|
Program Manager Position at Massachusetts General Hospital
"A clinical investigator within the Division of General Internal Medicine seeks a part-time
Program Manager (20 hrs. per week) to direct and oversee the work of a major NIH funded
clinical trial aimed at overcoming health disparities in Latinos with HIV through an innovative
psychosocial intervention. The PM will work directly with the PI (Julie Levison, MD)."
Full description and criteria here.
37th Annual Walk to End HIV! December 2nd at Anacostia Park
"The Walk to End HIV is more than just a fundraiser at Whitman-Walker. The Walk symbolizes our continued efforts to find a cure for HIV and to stop the stigma surrounding HIV. This fight will take the entire community's support and commitment." Register Here.
CDC Recruitment – Director of the Division of STD Prevention (DSTDP) and Director of the Division of HIV Prevention (DHP)
The Centers for Disease Control and Prevention (CDC) is recruiting exceptional candidates for two high-level positions: Director of the Division of STD Prevention (DSTDP) and Director of the Division of HIV Prevention (DHP). Both are leadership positions in the National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) and will play a key role in providing scientific leadership and expertise to manage, direct, coordinate, oversee, and evaluate a broad portfolio of activities of the respective Division.
Ryan White Program Coordinator @ Children's National Hospital, Position Open
"The Program Coordinator will provide administrative and program support to plan, implement and coordinate programs, events and educational activities, and to administer policies and procedures." See full job description, requirements, and application here.
American University, School of International Service, hiring Departmental Managers
"We are looking for strategic thinkers who can develop, manage, and implement administrative and operational policies, while helping to guide decision-making and goal-setting for our five new departments. BA degree + 3-5 years of relevant experience required."
Hablamos de TI Study (Now Recruiting Providers and Patient Interviews)
Owen Smith, RN PhD Candidate from Johns Hopkins School of Nursing is recruiting medical/psychosocial service providers working with Latino immigrant men living with HIV (LIMWH) and LIMWH themselves to participate in his dissertation study: Hablemos de TI. The Hablemos de TI study is focused on understanding the perspectives of LIMWH regarding their experiences with interpersonal trauma, emotional support, and engagement in HIV care. Interviews with providers and LIMWH will be conducted in either Spanish or English, will last approximately 1 hour, and can be conducted by phone or Zoom. Participants will be compensated for their time with a gift card. Interested providers can fill out the interest survey at: https://redcap.link/cv4nvocz . Interest survey link (in Spanish) to be shared with LIMWH clients: https://redcap.link/hkscgs1d For more information, contact, Owen Smith at: osmith7@jhmi.edu.
COVID-19 Treatment Study at Whitman Walker Institute
The SCORPIO-HR Study is a clinical research study looking at an investigational drug for COVID-19
in people who have tested positive and whether it: helps resolve COVID-19 symptoms faster; can reduce symptoms that persist for several months (called “long COVID”).
MUST HAVE TESTED POSITIVE IN THE LAST 72 HOURS TO PARTICIPATE. See more here.
| |
NIH FUNDING OPPORTUNITIES
| |
|
Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers
Funding Opportunity Number: RFA-PS-24-063
Posting Date: Oct 11, 2023
Opening Date: Nov 15, 2023
Close Date: Jan 16, 2024
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
Funding Opportunity Number: PAR-23-112
Posting Date: January 31, 2023
Opening Date: February 24, 2023
Close Date: Various – See announcement
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-018
Posting Date: August 21, 2023
Opening Date: July 5, 2024
Close Date: August 2024
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-001
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
Funding Opportunity Number: RFA-OD-23-018
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-22-248 (Reissue)
Posting Date: June 27, 2023
Opening Date: August 13, 2023
Close Date: Various – See announcement
| |
|
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-297
Posting Date: September 19, 2023
Opening Date: December 7, 2023
Close Date: Various – See announcement
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-296
Posting Date: September 19, 2023
Opening Date: December 7, 2023
Close Date: Various – See announcement
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-061
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-060
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
Funding Opportunity Number: NOT-MH-23-275
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Funding Opportunity Number: NOT-CA-23-070
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
| |
Click here for additional funding opportunities available from the National Institutes of Health. | |
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. | | |
| | | |
